Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Anglo American Platinum Ltd American Depositary Receipts - S | RPH1 | Jan 9, 2025 | 4.86 | +3.40 |
Anglo American PLC | NGLB | Jan 9, 2025 | 29.11 | +2.10 |
Anglo American plc Sponsored ADR (United Kingdom) | NGLD | Jan 9, 2025 | 13.70 | +0.74 |
Anglo Asian Mining | A4A | Jan 9, 2025 | 1.15 | -0.86 |
Anglo Pacific Group PLC | HGR | Jan 9, 2025 | 0.74 | -3.40 |
Angus Energy Plc | A3R | Jan 9, 2025 | 0.00 | 0.00 |
Anheuser-Busch Inbev SA Sponsored ADR (Belgium) | ITKA | Jan 9, 2025 | 46.60 | 0.00 |
Anheuser-Busch InBev SA/NV | 1NBA | Jan 9, 2025 | 47.68 | +0.48 |
ANHUI CONCH | AQE | Jan 9, 2025 | 2.40 | +2.26 |
ANHUI CONCH CEM.ADR/5 YC1 | AQE0 | Jan 9, 2025 | 11.50 | +0.88 |
Anhui Expressway Co | HU7 | Jan 9, 2025 | 1.27 | -0.78 |
ANI Pharmaceuticals, Inc. | BSFA | Jan 9, 2025 | 51.50 | -0.96 |
Anika Therapeutics Inc. | AKP | Jan 9, 2025 | 15.30 | +1.32 |
Anima Holding | 124 | Jan 9, 2025 | 6.43 | -4.03 |
Annaly Capital Management | AAYA | Jan 9, 2025 | 18.05 | +0.16 |
ANNEXIN PHARM. AB (PUBL) | Q91 | Jan 9, 2025 | 0.03 | -0.62 |
Annovis Bio, Inc. | 07X | Jan 9, 2025 | 5.08 | +5.29 |
Anonymous Intelligence | 1JIA | Jan 9, 2025 | 0.09 | -3.76 |
ANORTECH RES INC. | HR50 | Jan 9, 2025 | 0.01 | 0.00 |
Anoto Group | XTL1 | Jan 9, 2025 | 0.01 | 0.00 |
Anritsu Corporation | AN1 | Jan 9, 2025 | 7.65 | +0.66 |
Ansell Ltd. | PD1A | Jan 9, 2025 | 20.00 | -0.99 |
Ansell Ltd. | PD1 | Jan 9, 2025 | 73.00 | -0.68 |
Anson Resources Limited | 9MY | Jan 9, 2025 | 0.04 | -4.74 |
Answear.com S.A. | 90Z | Jan 9, 2025 | 6.24 | 0.00 |
ANSYS, Inc. | AKX | Jan 9, 2025 | 330.80 | +2.19 |
ANT.(RMB)CL.B HKD -,1 | 9MD0 | Jan 9, 2025 | 9.20 | +2.22 |
ANTA SPORTS | AS7 | Jan 9, 2025 | 9.70 | +5.21 |
Antares Vision S.p.a. | 2YK | Jan 9, 2025 | 3.23 | -1.68 |
Antengene Corporation Limited | 722 | Jan 9, 2025 | 0.07 | +0.73 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.